tradmap

KALA Earnings KALA BIO, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$108 -$54 $0 2020 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $6M $11M 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$143M -$71M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$156 -$78 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Net income (quarterly)
-$12M -$6M $686000 $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income
Return on equity (quarterly)
-177% 85% 348% 0% Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
ROE

Reported EPS history

1–23 of 23
Q2 20262026-06-30-0.212026-08-1910-Q
Q1 20262026-03-31-0.142026-05-1510-Q
FY 20252025-12-31-3.312026-04-1510-K
Q3 20252025-09-30-4.172025-11-1910-Q
Q2 20262025-06-30-156.322026-08-1910-Q
Q1 20262025-03-31-70.492026-05-1510-Q
FY 20252024-12-31-10.152026-04-1510-K
Q3 20252024-09-30-8.682025-11-1910-Q
Q2 20252024-06-30-7.322025-08-0810-Q
Q1 20252024-03-31-4.202025-05-1410-Q
FY 20242023-12-31-17.352025-03-3110-K
Q3 20242023-09-30-14.362024-11-1210-Q
Q2 20242023-06-30-11.152024-08-0610-Q
Q1 20232023-03-31-6.992023-05-0910-Q
FY 20232022-12-31-29.482024-03-2910-K
Q3 20232022-09-30-21.462023-11-1310-Q
Q2 20232022-06-30-41.102023-08-0410-Q
Q1 20232022-03-31-22.182023-05-0910-Q
FY 20222021-12-31-108.322023-03-0310-K
Q3 20222021-09-30-73.802022-11-0810-Q
Q2 20222021-06-30-1.062022-08-1110-Q
Q1 20222021-03-31-0.492022-05-1610-Q
FY 20212020-12-31-1.992022-03-2910-K

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.